Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - December 2024

Click here to read the articles and download the PDF

Did Industry Fumble the DSCSA Deadline?

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Going Inside the Gross-to-Net Bubble and Its Nuances

A crash course on the bubble itself, including therapeutic areas most affected.

Why AI Advances in CGT Require Getting Data Right

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Pharma Pulse 4/17/24: At-Home Patients and AI, Psychedelics Present Unique Ethical Challenges & more

April 17, 2024

The latest news for pharma industry insiders.

LogiPharma Europe 2024: Infusing Pulse into Your Supply Chain Operation

April 17, 2024

Masterclass session addresses looking beyond a dashboard by added capabilities with added value.

BioHarvest Sciences Expands Operations with New 80,000 Square Foot Facility in Yavne, Israel

April 16, 2024

Company also purchased equipment for 12 good manufacturing practice clean rooms.

Evergreen Theragnostics Raises $26M in Capital to Aid Commercialization Efforts for the Ga-68 DOTATOC Diagnostic Kit

April 16, 2024

Capital also expected to assist the advancement of Evergreen's radiopharmaceutical discovery pipeline into clinical trials.

Pharma Pulse 4/16/24: Diabetes Weight Loss Drugs Could Reduce Risk of MS, Walmart Health Expands in Texas & more

April 16, 2024

The latest news for pharma industry insiders.

Trial Findings for Minimally Invasive Parafascicular Technology Show Promise for Intracerebral Hemorrhage Treatment

April 15, 2024

Results of the trial suggest that early intervention for intracerebral hemorrhage using parafascicular surgery were safe.

Spinogenix’s Investigational New Drug Application for Novel Treatment for Fragile X Syndrome Cleared to Begin Phase II Trial

April 15, 2024

Phase IIa clinical trial of SPG60 for Fragile X syndrome offers hope for disease with no current FDA-approved treatment options.

Pharma Pulse 4/15/24: Increase in ransomware attacks to healthcare's remote access systems, The Health and Healthcare of Gen Xers & more

April 15, 2024

The latest news for pharma industry insiders.

Does the Use of Hepatitis C Antivirals Surge Following an Easing of Medicaid Coverage Restrictions?

April 12, 2024

A difference-in-differences analysis explores the correlation between direct-acting antiviral prescriptions for hepatitis C virus and the softening of state-level limitations.

Mitigating Drug Shortages

April 12, 2024

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.